{"component": "definition", "props": {"groups": [{"size": 19, "samples": [{"hash": "FqP4X806I2", "uri": "/contracts/FqP4X806I2#equity-agreements", "label": "Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.)", "score": 32.5373039246, "published": true}, {"hash": "21YulHc3wiS", "uri": "/contracts/21YulHc3wiS#equity-agreements", "label": "Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.)", "score": 32.4031486511, "published": true}, {"hash": "eXLYofB3gn2", "uri": "/contracts/eXLYofB3gn2#equity-agreements", "label": "Exclusive Channel Partner Agreement (Intrexon Corp)", "score": 28.1622180939, "published": true}], "snippet": "has the meaning set forth in Section 5.1.", "snippet_links": [{"key": "section-51", "type": "clause", "offset": [29, 40]}], "hash": "35e04d41cc9c73e4a7ee5ef3385bc143", "id": 1}, {"size": 13, "samples": [{"hash": "cBlQ6dTV8Mr", "uri": "/contracts/cBlQ6dTV8Mr#equity-agreements", "label": "Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "mNHm0OY40j", "uri": "/contracts/mNHm0OY40j#equity-agreements", "label": "Collaboration Agreement (Discovery Partners International Inc)", "score": 21.0, "published": true}, {"hash": "i3bRX4mtKZe", "uri": "/contracts/i3bRX4mtKZe#equity-agreements", "label": "Collaboration Agreement (Infinity Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "snippet": "means the Stock Purchase Agreement and the Investors\u2019 Rights Agreement.", "snippet_links": [{"key": "the-stock-purchase-agreement", "type": "clause", "offset": [6, 34]}, {"key": "the-investors", "type": "definition", "offset": [39, 52]}, {"key": "rights-agreement", "type": "clause", "offset": [54, 70]}], "hash": "49ac65cd7b6e5b0984d9a7219c65b663", "id": 2}, {"size": 11, "samples": [{"hash": "gz1GNzyk6s8", "uri": "/contracts/gz1GNzyk6s8#equity-agreements", "label": "Credit Agreement (Theragenics Corp)", "score": 21.0, "published": true}, {"hash": "6HgZ2vvLidX", "uri": "/contracts/6HgZ2vvLidX#equity-agreements", "label": "Credit Agreement (Theragenics Corp)", "score": 21.0, "published": true}, {"hash": "8eoNnzU2Nbz", "uri": "/contracts/8eoNnzU2Nbz#equity-agreements", "label": "Credit Agreement (Astec Industries Inc)", "score": 20.3545513153, "published": true}], "snippet": "means any and all agreements of whatever kind by, between or among Borrower and the Equity Owners of Borrower and relating to the Equity Interests.", "snippet_links": [{"key": "all-agreements", "type": "clause", "offset": [14, 28]}, {"key": "equity-owners", "type": "definition", "offset": [84, 97]}, {"key": "relating-to", "type": "definition", "offset": [114, 125]}, {"key": "the-equity-interests", "type": "clause", "offset": [126, 146]}], "hash": "226134b1b5013856bb4bdc5d789ad160", "id": 3}, {"size": 10, "samples": [{"hash": "hUPbhERA0dV", "uri": "/contracts/hUPbhERA0dV#equity-agreements", "label": "Severance Agreement (Nalco Holding CO)", "score": 21.0, "published": true}, {"hash": "atinQy31hUn", "uri": "/contracts/atinQy31hUn#equity-agreements", "label": "Severance Agreement (Nalco Holdings LLC)", "score": 21.0, "published": true}, {"hash": "9J0TttRreYg", "uri": "/contracts/9J0TttRreYg#equity-agreements", "label": "Severance Agreement (Nalco Holdings LLC)", "score": 21.0, "published": true}], "snippet": "means those Agreements executed simultaneously with this Agreement pursuant to which Executive is purchasing certain Units and restricted Units in Nalco LLC.", "snippet_links": [{"key": "simultaneously-with", "type": "clause", "offset": [32, 51]}, {"key": "this-agreement", "type": "clause", "offset": [52, 66]}, {"key": "pursuant-to", "type": "clause", "offset": [67, 78]}, {"key": "restricted-units", "type": "definition", "offset": [127, 143]}], "hash": "0df57c8ce9dbc959f58c0bd74026b1fb", "id": 4}, {"size": 7, "samples": [{"hash": "exAkl3OVV7g", "uri": "/contracts/exAkl3OVV7g#equity-agreements", "label": "Research Collaboration and License Agreement (Neumora Therapeutics, Inc.)", "score": 34.6454467773, "published": true}, {"hash": "8Ut7xEuLuIM", "uri": "/contracts/8Ut7xEuLuIM#equity-agreements", "label": "Exclusive License Agreement (Neumora Therapeutics, Inc.)", "score": 34.6454467773, "published": true}, {"hash": "7uyCthTPTXf", "uri": "/contracts/7uyCthTPTXf#equity-agreements", "label": "Exclusive License Agreement (Neumora Therapeutics, Inc.)", "score": 34.6454467773, "published": true}], "snippet": "has the meaning set forth in the recitals hereto.", "snippet_links": [{"key": "the-recitals", "type": "clause", "offset": [29, 41]}], "hash": "8bd63ccb15b2b85d790cc990cc4b7390", "id": 5}, {"size": 5, "samples": [{"hash": "8BsKfXNZrcS", "uri": "/contracts/8BsKfXNZrcS#equity-agreements", "label": "License and Collaborative Research Agreement (Intellia Therapeutics, Inc.)", "score": 31.3429164886, "published": true}, {"hash": "e4QAV4LWh79", "uri": "/contracts/e4QAV4LWh79#equity-agreements", "label": "License and Collaborative Research Agreement (Intellia Therapeutics, Inc.)", "score": 26.3408622742, "published": true}, {"hash": "IfnetTrdxl", "uri": "/contracts/IfnetTrdxl#equity-agreements", "label": "License and Collaborative Research Agreement (Intellia Therapeutics, Inc.)", "score": 26.2970561981, "published": true}], "snippet": "means that Unit Purchase Agreement, dated September 17, 2014, by and among Intellia Therapeutics, LLC, Atlas Venture Fund IX, L.P. and Novartis, and that Amended and Restated Operating Agreement of Intellia Therapeutics, LLC, dated as of September 17, 2014, each as amended, waived or superseded from time to time.", "snippet_links": [{"key": "unit-purchase-agreement", "type": "definition", "offset": [11, 34]}, {"key": "fund-ix", "type": "definition", "offset": [117, 124]}, {"key": "amended-and-restated-operating-agreement", "type": "clause", "offset": [154, 194]}, {"key": "dated-as-of", "type": "definition", "offset": [226, 237]}, {"key": "as-amended", "type": "definition", "offset": [263, 273]}, {"key": "from-time-to-time", "type": "clause", "offset": [296, 313]}], "hash": "6a3fe7fecf9e8b996dd58a9e3b73bea1", "id": 6}, {"size": 5, "samples": [{"hash": "daAyJ8Ads9q", "uri": "/contracts/daAyJ8Ads9q#equity-agreements", "label": "Registration Rights Agreement (American Tower Corp /Ma/)", "score": 18.0, "published": true}, {"hash": "cU95dSayA9O", "uri": "/contracts/cU95dSayA9O#equity-agreements", "label": "Registration Rights Agreement (American Tower Corp /Ma/)", "score": 18.0, "published": true}, {"hash": "agV2S3eXt7A", "uri": "/contracts/agV2S3eXt7A#equity-agreements", "label": "Registration Rights Agreement (Iron Mountain Inc /De)", "score": 18.0, "published": true}], "snippet": "means all of the foregoing agreements.", "snippet_links": [{"key": "the-foregoing", "type": "clause", "offset": [13, 26]}], "hash": "e60f1ae6190b9f705889ab85146a9f8a", "id": 7}, {"size": 4, "samples": [{"hash": "5cQqF2meUdM", "uri": "/contracts/5cQqF2meUdM#equity-agreements", "label": "Development, Promotion, Distribution and Supply Agreement", "score": 21.0, "published": true}, {"hash": "bTnqYuI9D1g", "uri": "/contracts/bTnqYuI9D1g#equity-agreements", "label": "Development, Promotion, Distribution and Supply Agreement (Bristol Myers Squibb Co)", "score": 18.0, "published": true}, {"hash": "7Uqn8C71oSd", "uri": "/contracts/7Uqn8C71oSd#equity-agreements", "label": "Development, Promotion, Distribution and Supply Agreement (Imclone Systems Inc/De)", "score": 18.0, "published": true}], "snippet": "shall have the meaning assigned to such term in the preliminary statements.", "snippet_links": [{"key": "preliminary-statements", "type": "definition", "offset": [52, 74]}], "hash": "57c1d395da9323fb20ab0b337eabe0cb", "id": 8}, {"size": 4, "samples": [{"hash": "8WEy9hfpyuX", "uri": "/contracts/8WEy9hfpyuX#equity-agreements", "label": "Collaboration Agreement (Coherus BioSciences, Inc.)", "score": 35.2012329102, "published": true}, {"hash": "5FakLyB0nmv", "uri": "/contracts/5FakLyB0nmv#equity-agreements", "label": "Collaboration Agreement (Surface Oncology, Inc.)", "score": 29.2217655182, "published": true}, {"hash": "a77nconioih", "uri": "/contracts/a77nconioih#equity-agreements", "label": "Collaboration Agreement (Surface Oncology, Inc.)", "score": 29.1724853516, "published": true}], "snippet": "means (a) Series A-1 Stock Purchase Agreement, by and among Surface and the Purchaser listed on Schedule 1 thereto, dated as of the Effective Date; (b) Amendment No. 1 to Investors\u2019 Rights Agreement, by and among Surface and the investors party thereto, dated as of the Effective Date; (c) Amendment No. 1 to Voting Agreement, by and among Surface and the stockholders party thereto, dated as of the Effective Date; (d) Amendment No. 1 to Right of First Refusal and Co-Sale Agreement, by and among Surface and the stockholders party thereto, dated as of the Effective Date; and (e) Participation Agreement, by and between Surface and Novartis, dated as of the Effective Date, in each case ((a)-(e)) as may be amended or restated from time to time.", "snippet_links": [{"key": "series-a-1-stock-purchase-agreement", "type": "definition", "offset": [10, 45]}, {"key": "and-the-purchaser", "type": "clause", "offset": [68, 85]}, {"key": "schedule-1", "type": "clause", "offset": [96, 106]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [122, 146]}, {"key": "amendment-no", "type": "definition", "offset": [152, 164]}, {"key": "rights-agreement", "type": "clause", "offset": [182, 198]}, {"key": "the-investors", "type": "definition", "offset": [225, 238]}, {"key": "voting-agreement", "type": "clause", "offset": [309, 325]}, {"key": "the-stockholders", "type": "clause", "offset": [352, 368]}, {"key": "right-of-first-refusal-and-co", "type": "definition", "offset": [439, 468]}, {"key": "sale-agreement", "type": "definition", "offset": [469, 483]}, {"key": "participation-agreement", "type": "clause", "offset": [582, 605]}, {"key": "each-case", "type": "definition", "offset": [679, 688]}, {"key": "from-time-to-time", "type": "clause", "offset": [729, 746]}], "hash": "f9a27336284f77443fe82a22dad6e21d", "id": 9}, {"size": 4, "samples": [{"hash": "5l1IXryE63E", "uri": "https://www.sec.gov/Archives/edgar/data/1015535/000119312504085968/dex41.htm", "label": "Supplemental Indenture (Amf Bowling Worldwide Inc)", "score": 12.0, "published": false}], "snippet": "means the stockholders agreement and other equity arrangements entered into in connection with the Acquisition.", "snippet_links": [{"key": "the-stockholders-agreement", "type": "clause", "offset": [6, 32]}, {"key": "equity-arrangements", "type": "clause", "offset": [43, 62]}, {"key": "entered-into", "type": "clause", "offset": [63, 75]}, {"key": "in-connection-with", "type": "clause", "offset": [76, 94]}, {"key": "the-acquisition", "type": "clause", "offset": [95, 110]}], "hash": "29780f61eb30a4021bdd2210f936ca7d", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIaZXF1aXR5LWFncmVlbWVudHMjMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 168, "title": "Equity Agreements", "snippet": "has the meaning set forth in Section 5.1.", "id": "equity-agreements", "examples": ["Regardless of the circumstances of the Executive\u2019s termination, Executive shall be entitled to payment when due of any earned and unpaid base salary, expense reimbursements and vacation days accrued prior to the termination of Executive\u2019s employment, and other unpaid vested amounts or benefits under Company retirement and health benefit plans, and, as applicable, under <strong>Equity Agreements</strong> in accordance with their terms, and to no other compensation or benefits.", "This Agreement and the Confidentiality Agreement between the parties constitute the entire agreement between the parties and supersede any and all prior contracts, agreements, or understandings between the parties which may have been entered into by Company and the Executive relating to the subject matter hereof (including, without limitation, the Prior Severance Agreement), except for the <strong>Equity Agreements</strong>, which are to remain in full force and effect.", "The exercise of any stock options and the settlement of any restricted stock units shall continue to be subject to the terms and conditions of the <strong>Equity Agreements</strong> and the Employment Agreement.", "The Company and you acknowledge and agree that each party has continuing obligations to the other party under the Employment Agreement, the Indemnification Rights, and Equity Plan and <strong>Equity Agreements</strong>.", "Accordingly, the Company and you acknowledge and agree that, to the extent expressly provided in each agreement, the Employment Agreement, Indemnification Rights and Equity Plan and <strong>Equity Agreements</strong> shall remain in full force and effect in accordance with their respective terms.", "These <strong>Equity Agreements</strong> provide vesting schedules, performance metrics, if any, and other material terms of each grant.", "Upon a Transfer of all of a Unitholder\u2019s Units in a Transfer permitted by this Agreement, and (if applicable) the <strong>Equity Agreements</strong>, such Unitholder shall cease to be a Unitholder.", "Further, notwithstanding the preceding sentence, in the event disputes arise that relate in any way to and concern this Agreement and also relate in any way to and concern one or more other <strong>Equity Agreements</strong>, the Parties agree that such disputes may be joined in a single binding arbitration if doing so would not result in unreasonable delay.", "To the extent not specifically provided for herein, the vesting and exercisability of equity and equity-based awards (if any) held by the Executive at termination, and all other terms of such equity and equity-based awards (if any), shall be governed by the <strong>Equity Agreements</strong>.", "If the Executive\u2019s employment is terminated during the Employment Period by the Company for Cause or voluntarily by the Executive other than for Good Reason, the Company shall pay the Executive upon the Date of Termination the Accrued Benefits and the Other Benefits and any benefits or compensation provided under the <strong>Equity Agreements</strong> which shall be paid in accordance with such agreements."], "related": [["acquisition-agreements", "Acquisition Agreements", "Acquisition Agreements"], ["investment-agreements", "Investment Agreements", "Investment Agreements"], ["existing-agreements", "Existing Agreements", "Existing Agreements"], ["vie-agreements", "VIE Agreements", "VIE Agreements"], ["retention-agreements", "Retention Agreements", "Retention Agreements"]], "related_snippets": [], "updated": "2025-12-20T05:53:03+00:00"}, "json": true, "cursor": ""}}